BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Evans K, Romero H, Spierings EL, Katz N. The relation between the placebo response, observed treatment effect, and failure to meet primary endpoint: A systematic review of clinical trials of preventative pharmacological migraine treatments. Cephalalgia 2021;41:247-55. [PMID: 32960658 DOI: 10.1177/0333102420960020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Tepper SJ, Cirillo J, Kim E, L'italien G, Tweedie J, Lodaya K, Riley D, Pathan F, Antaki N, Nathanson BH, Mcallister P. The Temporal Trend of Placebo Response in Migraine Prevention from 1990 to 2021: A Systematic Literature Review and Meta-Analysis with Regression.. [DOI: 10.21203/rs.3.rs-2460023/v1] [Reference Citation Analysis]
2 Spavieri JHP, Ferreira PG. The importance of considering psychosocial aspects in migraine patients. HM 2022. [DOI: 10.48208/headachemed.2021.55] [Reference Citation Analysis]
3 Vandervorst F, Van Deun L, Van Dycke A, Paemeleire K, Reuter U, Schoenen J, Versijpt J. CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs. J Headache Pain 2021;22:128. [PMID: 34696711 DOI: 10.1186/s10194-021-01335-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 8.5] [Reference Citation Analysis]